Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 1/1997

01-01-1997 | ORIGINAL

The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock

Authors: A. Meier-Hellmann, D. L. Bredle, M. Specht, C. Spies, L. Hannemann, K. Reinhart

Published in: Intensive Care Medicine | Issue 1/1997

Login to get access
Metadata
Title
The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock
Authors
A. Meier-Hellmann
D. L. Bredle
M. Specht
C. Spies
L. Hannemann
K. Reinhart
Publication date
01-01-1997
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 1/1997
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s001340050287

Other articles of this Issue 1/1997

Intensive Care Medicine 1/1997 Go to the issue

BRIEF REPORT

The effects of inverse ratio ventilation on intracranial pressure: a preliminary report

ORIGINAL

Normal values of SvO2 as therapeutic goal in patients with multiple injuries

BRIEF REPORT

Increased lactate/pyruvate ratio with normal b-hydroxybutyrate/acetoacetate ratio and lack of oxygen supply dependency in a patient with fatal septic shock

GUIDELINES

Continuous quality improvement in the ICU: general guidelines

ORIGINAL

Comparison of the APACHE III, APACHE II and Glasgow Coma Scale in acute head injury for prediction of mortality and functional outcome

ORIGINAL

Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process